Risk HLA Variants Affect the T-Cell Repertoire in Multiple Sclerosis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 2, 2022
- Accepted in final form December 14, 2022
- First Published February 15, 2023.
Author Disclosures
- Melissa Sorosina, PhD,
- Silvia Santoro, PhD,
- Laura Ferrè, MD, PhD,
- Elisabetta Mascia, PhD,
- Ferdinando Clarelli, MS,
- Antonino Giordano, MD,
- Miryam Cannizzaro, MD,
- Moiola Lucia, MD,
- Vittorio Martinelli, MD,
- Massimo Filippi, MD and
- Federica Esposito, MD, PhD
- Melissa Sorosina, PhD,
None
NONE
None
Genes, Guest editor, 2022
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Italian ministry of Health, GR-2019-12368672, principal investigator, 2021-2024
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Silvia Santoro, PhD,
None
NONE
None
Genes, special issue: Genetic and Molecular Mechanisms in Multiple Sclerosis. Guest Editor. 2022.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
University Vita Salute San Raffaele
None
NONE
NONE
NONE
NONE
NONE
NONE
- Laura Ferrè, MD, PhD,
None
NONE
Laura Ferrè received travel or speaker honoraria from Novartis and Bristol Myers Squibb.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Elisabetta Mascia, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Ferdinando Clarelli, MS,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Antonino Giordano, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Miryam Cannizzaro, MD,
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Moiola Lucia, MD,
None
NONE
I received travel and speaker honoraria from Biogen, Merck, Sanofi-Genzyme, Celgene, Novartis, Roche, Alexion
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Vittorio Martinelli, MD,
Dr V Martinelli has participated in scientific advisory boards for Merck Serono and Genzyme
NONE
Dr Martinelli received travel supports and speakers honoraria for activities with Biogen Idec, Merck Serono, Teva Pharma, Novartis, Almirall and Genzyme
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Massimo Filippi, MD and
1) commercial entity: Alexion2) commercial entity: Biogen3) commercial entity: Bristol-Myers Squibb4) commercial entity: Merck5) commercial entity: Novartis6) commercial entity: Roche7) commercial entity: Sanofi8) commercial entity: Sanofi-Aventis9) commercial entity: Sanofi-Genzyme10) commercial entity: Takeda
NONE
1) commercial entity: Bayer, speaker honoraria 2) commercial entity: Biogen, speaker honoraria3) commercial entity: Celgene, speaker honoraria4) commercial entity: Chiesi Italia SpA, speaker honoraria5) commercial entity: Eli Lilly, speaker honoraria6) commercial entity: Genzyme, speaker honoraria7) commercial entity: Janssen, speaker honoraria8) commercial entity: Merck-Serono, speaker honoraria9) commercial entity: Neopharmed Gentili, speaker honoraria10) commercial entity: Novartis, speaker honoraria11) commercial entity: Novo Nordisk, speaker honoraria12) commercial entity: Roche, speaker honoraria13) commercial entity: Sanofi, speaker honoraria14) commercial entity: Takeda, speaker honoraria15) commercial entity: TEVA, speaker honoraria
Editor-in-Chief (2012-present), Journal of Neurology; Associate Editor, Neurological Sciences (2016-present); Associate Editor, Human Brain Mapping (since 2020)Associate Editor, Radiology (since 2015)
NONE
NONE
NONE
1) commercial entity: Alexion2) commercial entity: Almirall3) commercial entity: Biogen4) commercial entity: Merck5) commercial entity: Novartis6) commercial entity: Roche7) commercial entity: Sanofi
NONE
NONE
NONE
1) Commercial entity: Biogen Idec2) Commercial entity: Merck-Serono3) Commercial entity: Novartis4) Commercial entity: Roche
1) Italian Ministry of Health; grant number: RF-2018-12366746; role: PI; duration: 15/06/2020 – 14/06/2023
NONE
1) Fondazione Italiana Sclerosi Multipla (FISM)2) ARiSLA (Fondazione Italiana di Ricerca per la SLA)
NONE
NONE
NONE
NONE
NONE
NONE
- Federica Esposito, MD, PhD
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- From the Laboratory of Neurological Complex Disorders (M.S., S.S., L.F., E.M., F.C., A.G., M.C., F.E.), Division of Neuroscience, Institute of Experimental Neurology (INSPE), IRCCS San Raffaele Scientific Institute; Neurology and Neurorehabilitation Unit (L.F., A.G., M.C., M.L., V.M., M.F., F.E.), IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University (M.F.); Neurophysiology Unit (M.F.), IRCCS San Raffaele Scientific Institute; and Neuroimaging Research Unit, Division of Neuroscience, Institute of Experimental Neurology (INSPE) (P.F.), IRCCS San Raffaele Scientific Institute, Milan, Italy.
- Correspondence
Dr. Esposito esposito.federica{at}hsr.it
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. David E. Vaillancourt and Dr. Shannon Y. Chiu
► Watch
Related Articles
- No related articles found.